Addressing the Incremental Benefit of Histamine Dihydrochloride When Added to Interleukin-2 in Treating Acute Myeloid Leukemia: A Bayesian Meta-Analysis

Author： Berry Scott M.   Broglio Kristine R.   Berry Donald A.  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.29, Iss.4, 2011-04, pp. : 293-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma

By Perz Jolanta B   Ho Anthony D  

Future Oncology, Vol. 4, Iss. 2, 2008-04 ,pp. : 169-177

Future Medicine

Access to resources Recommend Favorite

Genetic polymorphisms of RAD51 and XRCC3 and acute myeloid leukemia risk: a meta-analysis

By Li Cuiping   Liu Yun   Hu Zhen   Zhou Yang  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1309-1319

Informa Healthcare

Access to resources Recommend Favorite

Prognostic significance of vascular endothelial growth factor expression in adult patients with acute myeloid leukemia: a meta-analysis

By Guo Baoping   Liu Yan   Tan Xiaohong   Cen Hong  

Leukemia and Lymphoma, Vol. 54, Iss. 7, 2013-07 ,pp. : 1418-1425

Informa Healthcare

Access to resources Recommend Favorite

Implications of lipocalin 2 expression in acute myeloid leukemia

By Frankfurt Olga   Platanias Leonidas C.  

Leukemia and Lymphoma, Vol. 54, Iss. 8, 2013-08 ,pp. : 1573-1574

Informa Healthcare

Access to resources Recommend Favorite

Infections in acute myeloid leukemia: an analysis of 382 febrile episodes

By Gupta Ajay  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1037-1045

Humana Press, Inc

Access to resources Recommend Favorite